Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLORAL1: Oral and Intravenous Antibiotic Prophylaxis in Colorectal Surgery
NCT04438655Completed
- Sponsor
- University of Turin
- Start
- May 2019
- Primary completion
- Nov 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Bimixin in surgical site infection (SSI) (2 arms), sponsored by University of Turin. Primary endpoint: Incidence of surgical site infections (superficial or deep) at 30 days. Started May 2019; status: completed.
02
Drugs
Bimixin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04438655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438655.